Publications by authors named "Angray Kang"

Claim this Profile
C
Clinical opinions and case studies on understanding and managing hypogammaglobulinaemia in multiple sclerosis: United Kingdom perspective.
Sharmilee Gnanapavan, Angray Kang, David Baker, Gavin Giovanonni

Mult Scler Relat Disord· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eukaryotic ribosome display for antibody discovery: A review.
Randy Chance, Angray Singh Kang

Hum Antibodies· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of biologics used in the treatment of asthma.
Omario A M Neunie, Wardah Rabbani, David Baker, Emma S Chambers, Paul E Pfeffer, Angray S Kang

Hum Antibodies· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis.
David Baker, Angray S Kang, Gavin Giovannoni, Klaus Schmierer

Mult Scler Relat Disord· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the 'N-terminal arm' & 'Convex surface' Binding Interfaces of the T3SS Chaperone-Translocator Complexes from P. Aeruginosa.
Charlotte L Frankling, Megan F Downes, Angray S Kang, Ewan R G Main

J Mol Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.
Safiya A Zaloum, Callum H Wood, Pooja Tank, Mae Upcott, Nicola Vickaryous, Angray S Kang

Mult Scler· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the "N-Terminal Anchor" Binding Interface of the T3SS Chaperone-Translocator Complexes from .
Charlotte L Frankling, Angray S Kang, Ewan R G Main

Biochemistry· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination.
David Baker, Eugenia Forte, Gareth Pryce, Angray S Kang, Louisa K James

Mult Scler Relat Disord· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis.
Emma C Tallantyre, Martin J Scurr, Nicola Vickaryous, Aidan Richards, Valerie Anderson, Angray S Kang

Mult Scler Relat Disord· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
David Baker, Amy MacDougall, Angray S Kang, Klaus Schmierer, Gavin Giovannoni

Clin Exp Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Response in People with Multiple Sclerosis.
Emma C Tallantyre, Nicola Vickaryous, Valerie Anderson, Aliye Nazli Asardag, David Baker, Angray S Kang

Ann Neurol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis.
David Baker, Amy MacDougall, Angray S Kang, Klaus Schmierer, Gavin Giovannoni

Mult Scler Relat Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of biologics used in the treatment of inflammatory bowel disease.
Mariam Bqain, Alex Efimov, David Baker, Angray S Kang

Hum Antibodies· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis.
David Baker, A Nazli Asardag, Olivia A Quinn, Alex Efimov, Angray S Kang

Hum Antibodies· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of biologics used in the treatment of moderate to severe psoriasis.
Visha Patel, Alex Efimov, David Baker, Angray S Kang

Hum Antibodies· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies.
David Baker, Liaqat Ali, Gauri Saxena, Gareth Pryce, Meleri Jones, Angray S Kang

Front Immunol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New mouthwash: an efficacious intervention for oral ulceration associated with Behçet's disease.
Amal Senusi, Angray Kang, John A G Buchanan, Adebowale Adesanya, Ghfren Aloraini

Br J Oral Maxillofac Surg· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.
David Baker, Sandra Amor, Angray S Kang, Klaus Schmierer, Gavin Giovannoni

Mult Scler Relat Disord· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting and predicting neutralization of alemtuzumab responses in MS.
Gauri Saxena, James M Moore, Meleri Jones, Gareth Pryce, Liaqat Ali, Angray S Kang

Neurol Neuroimmunol Neuroinflamm· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the T cell response to COVID-19.
Junwei Li, Junhua Wang, Angray S Kang, Pradeep Kumar Sacitharan

Signal Transduct Target Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of p53 in keratinocyte cultures treated with Behçet's patient sera.
Sihem Houacine, Angray Kang, Eric Kenneth Parkinson, Hong Wan, Farida Fortune

J Oral Pathol Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cell-based assay for the detection of neutralizing antibodies against alemtuzumab.
Liaqat Ali, Gauri Saxena, Meleri Jones, Georgia R Leisegang, Luke Gammon, Angray S Kang

Biotechniques· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin exacerbates influenza infection in elderly individuals via IL-18.
Youzhu Jiang, Changhua Yi, Yongxiang Yi, Qingwen Jin, Angray S Kang

Signal Transduct Target Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains.
Gauri K Saxena, Ioannis Theocharopoulos, Nisha Thaslima Aziz, Meleri Jones, Sharmilee Gnanapavan, Angray S Kang

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the Desmosomal Cadherin Desmoglein-3 in Regulating YAP and Phospho-YAP in Keratinocyte Responses to Mechanical Forces.
Jutamas Uttagomol, Usama Sharif Ahmad, Ambreen Rehman, Yunying Huang, Ana C Laly, Angray Kang

Int J Mol Sci· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis